Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 3976 AL 3990

Rabs, Membrane Dynamics, and Parkinson's Disease

Tang BL.

J Cell Physiol. 2017 Jul;232(7):1626-1633. doi: 10.1002/jcp.25713. Epub 2016 Dec 20.

Clinicopathological case: progressive cognitive decline with gait disturbance in a steel worker

Moreton FC, Brenner R, Lazarus J, Davenport R.

Pract Neurol. 2017 Apr;17(2):159-166. doi: 10.1136/practneurol-2016-001527. Epub 2016 Dec 7.

Ethical clinical translation of stem cell interventions for neurologic disease

Cote DJ, Bredenoord AL, Smith TR, Ammirati M, Brennum J, Mendez I, Ammar AS, Balak N, Bolles G, Esene IN, Mathiesen T, Broekman ML.

Neurology. 2017 Jan 17;88(3):322-328. doi: 10.1212/WNL.0000000000003506. Epub 2016 Dec 7.

Cigarette smoke and related risk factors in neurological disorders: An update

G SB, Choi S, Krishnan J, K R.

Biomed Pharmacother. 2017 Jan;85:79-86. doi: 10.1016/j.biopha.2016.11.118. Epub 2016 Dec 5.

The Cellular Diversity of the Pedunculopontine Nucleus: Relevance to Behavior in Health and Aspects of Parkinson's Disease

Pienaar IS, Vernon A, Winn P.

Neuroscientist. 2017 Aug;23(4):415-431. doi: 10.1177/1073858416682471. Epub 2016 Dec 7.

Comparative analysis of speech impairment and upper limb motor dysfunction in Parkinson's disease

Rusz J, Tykalová T, Krupička R, Zárubová K, Novotný M, Jech R, Szabó Z, Růžička E.

J Neural Transm (Vienna). 2017 Apr;124(4):463-470. doi: 10.1007/s00702-016-1662-y. Epub 2016 Dec 8.

Neuroprotection of Granulocyte Colony-Stimulating Factor for Early Stage Parkinson's Disease

Tsai ST, Chu SC, Liu SH, Pang CY, Hou TW, Lin SZ, Chen SY.

Cell Transplant. 2017 Mar 13;26(3):409-416. doi: 10.3727/096368916X694247. Epub 2016 Dec 7.

Treatment of cognitive impairment in Parkinson disease

Gasca-Salas C.

Med Clin (Barc). 2017 Mar 3;148(5):232-237. doi: 10.1016/j.medcli.2016.10.027. Epub 2016 Dec 7.

Protective roles of melatonin in central nervous system diseases by regulation of neural stem cells

Yu X, Li Z, Zheng H, Ho J, Chan MT, Wu WK.

Cell Prolif. 2017 Apr;50(2):e12323. doi: 10.1111/cpr.12323. Epub 2016 Dec 12.

Effects of α-synuclein on axonal transport

Volpicelli-Daley LA.

Neurobiol Dis. 2017 Sep;105:321-327. doi: 10.1016/j.nbd.2016.12.008. Epub 2016 Dec 9.

Prevalence and treatment of LUTS in patients with Parkinson disease or multiple system atrophy

Ogawa T, Sakakibara R, Kuno S, Ishizuka O, Kitta T, Yoshimura N.

Nat Rev Urol. 2017 Feb;14(2):79-89. doi: 10.1038/nrurol.2016.254. Epub 2016 Dec 13.

PINK1 signaling in mitochondrial homeostasis and in aging (Review)

Kitagishi Y, Nakano N, Ogino M, Ichimura M, Minami A, Matsuda S.

Int J Mol Med. 2017 Jan;39(1):3-8. doi: 10.3892/ijmm.2016.2827. Epub 2016 Dec 12.

Improvement of Pyramidal Tract Side Effect Prediction Using a Data-Driven Method in Subthalamic Stimulation

Baumgarten C, Zhao Y, Sauleau P, Malrain C, Jannin P, Haegelen C.

IEEE Trans Biomed Eng. 2017 Sep;64(9):2134-2141. doi: 10.1109/TBME.2016.2638018. Epub 2016 Dec 9.

Developing drugs that target the Wnt pathway: recent approaches in cancer and neurodegenerative diseases

Serafino A, Sferrazza G, Colini Baldeschi A, Nicotera G, Andreola F, Pittaluga E, Pierimarchi P.

Expert Opin Drug Discov. 2017 Feb;12(2):169-186. doi: 10.1080/17460441.2017.1271321. Epub 2016 Dec 26.

Role of the VPS35 D620N mutation in Parkinson's disease

Mohan M, Mellick GD.

Parkinsonism Relat Disord. 2017 Mar;36:10-18. doi: 10.1016/j.parkreldis.2016.12.001. Epub 2016 Dec 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias